![]() Our underlying ROE medium-term financial objective will change to 18%+ following the adoption of both standards, an increase from 16%+ prior to transition. See section I - Capital and Liquidity Management - 3 - Shareholder Dividends our 2022 Annual MD&A for further information regarding dividends.ĤOur medium-term financial objectives following the adoption of IFRS 17 and IFRS 9 remain consistent for underlying earnings per share and underlying dividend payout ratio. Underlying dividend payout ratio represents the ratio of common shareholders' dividends to diluted underlying EPS. See section L - Non-IFRS Financial Measures in our 2022 Annual MD&A for further information. See section L - Non-IFRS Financial Measures in our 2022 Annual MD&A for further information.ģUnderlying EPS, underlying ROE and underlying dividend payout ratio are non-IFRS financial measures. For values to the nearest million, see section C - Financial Summary in our 2022 Annual Management’s Discussion and Analysis (“2022 Annual MD&A”).ĢRepresents a non-IFRS financial measure. ![]() ![]() 1The full year 2022 results values have been rounded and are in Canadian dollars.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |